Kristen Nadeau

Vice Chair for Clinical and Translational Research · University of Colorado School of Medicine

Credentials: · · ·

History

What Activates Type 2 Diabetes in Children (WATCH)
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $2M · University of Colorado Denver
2023–2029
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.4M · University of Colorado Denver
2022–2027
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $3.3M · Cincinnati Childrens Hosp Med Ctr
2019–2025
The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers
National Heart, Lung, and Blood Institute · K24
Contact PI · $574.5K · University of Colorado Denver
2019–2023

Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Principal investigator · Recruiting · Phase 3
University of Colorado, Denver
2023–2027
Surgical or Medical Treatment
Principal investigator · Active not recruiting · Phase 4
Children's Hospital Medical Center, Cincinnati
2019–2026
Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes
Principal investigator · Completed · Phase 2
University of Colorado, Denver
2015–2019
EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes
Principal investigator · Completed · Phase 3
University of Colorado, Denver
2013–2016